Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    Race-specific geography of prostate cancer incidence.

    DeChello LM, Gregorio DI, Samociuk H.

    Int J Health Geogr. 2006 Dec 18;5:59.

    PMID:
    17176460
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

    Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR.

    J S C Med Assoc. 2006 Aug;102(7):241-9. Review.

    PMID:
    17319238
    [PubMed - indexed for MEDLINE]
    3.

    Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.

    Platz EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E.

    J Natl Cancer Inst. 2000 Dec 20;92(24):2009-17.

    PMID:
    11121463
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Trends in prostate carcinoma incidence in Connecticut (1988-1994) by age and race.

    Polednak AP.

    Cancer. 1997 Jan 1;79(1):99-103.

    PMID:
    8988732
    [PubMed - indexed for MEDLINE]
    5.

    Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999.

    Wu X, Chen VW, Martin J, Roffers S, Groves FD, Correa CN, Hamilton-Byrd E, Jemal A; Comparative Analysis of Incidence Rates Subcommittee, Data Evaluation and Publication Committee, North American Association of Central Cancer Registries.

    Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1215-22.

    PMID:
    15247133
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Stage at diagnosis of prostate cancer in Connecticut by poverty and race.

    Polednak AP.

    Ethn Dis. 1997 Autumn;7(3):215-20.

    PMID:
    9467704
    [PubMed - indexed for MEDLINE]
    7.

    Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999.

    Oliver MN, Smith E, Siadaty M, Hauck FR, Pickle LW.

    Am J Prev Med. 2006 Feb;30(2 Suppl):S67-76.

    PMID:
    16458792
    [PubMed - indexed for MEDLINE]
    9.

    Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status.

    Vijayakumar S, Weichselbaum R, Vaida F, Dale W, Hellman S.

    Cancer J Sci Am. 1996 Jul-Aug;2(4):225-33.

    PMID:
    9166537
    [PubMed - indexed for MEDLINE]
    10.

    Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada.

    Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS.

    Cancer Causes Control. 2002 Jun;13(5):471-82.

    PMID:
    12146852
    [PubMed - indexed for MEDLINE]
    11.

    Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks.

    Gilliland FD, Becker TM, Key CR, Samet JM.

    Cancer. 1994 Apr 15;73(8):2192-9.

    PMID:
    8156525
    [PubMed - indexed for MEDLINE]
    12.

    Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

    Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.

    Med Care. 2004 Mar;42(3):239-50.

    PMID:
    15076823
    [PubMed - indexed for MEDLINE]
    13.

    Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States).

    Krieger N, Quesenberry C Jr, Peng T, Horn-Ross P, Stewart S, Brown S, Swallen K, Guillermo T, Suh D, Alvarez-Martinez L, Ward F.

    Cancer Causes Control. 1999 Dec;10(6):525-37.

    PMID:
    10616822
    [PubMed - indexed for MEDLINE]
    14.

    Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

    Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A.

    J Gen Intern Med. 2004 Feb;19(2):146-55.

    PMID:
    15009794
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Hierarchical modeling and other spatial analyses in prostate cancer incidence data.

    Mather FJ, Chen VW, Morgan LH, Correa CN, Shaffer JG, Srivastav SK, Rice JC, Blount G, Swalm CM, Wu X, Scribner RA.

    Am J Prev Med. 2006 Feb;30(2 Suppl):S88-100.

    PMID:
    16458795
    [PubMed - indexed for MEDLINE]
    16.

    Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.

    Zagars GK, Pollack A, Pettaway CA.

    Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):517-23.

    PMID:
    9806509
    [PubMed - indexed for MEDLINE]
    17.

    Analysis of prostate cancer incidence using geographic information system and multilevel modeling.

    Xiao H, Gwede CK, Kiros G, Milla K.

    J Natl Med Assoc. 2007 Mar;99(3):218-25.

    PMID:
    17393945
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    19.

    Race/ethnicity and the perception of the risk of developing prostate cancer.

    Shavers VL, Underwood W, Moser RP.

    Am J Prev Med. 2009 Jul;37(1):64-7. Epub 2009 May 7.

    PMID:
    19423272
    [PubMed - indexed for MEDLINE]
    20.

    Stress, coping, social support, and prostate cancer risk among older African American and Caucasian men.

    Coker AL, Sanderson M, Ellison GL, Fadden MK.

    Ethn Dis. 2006 Autumn;16(4):978-87.

    PMID:
    17061756
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk